Categories: NewsRobotics

TMRW Life Sciences Announces Launch of its Latest Offering in Frozen IVF Specimen Management and Storage: TMRW Vault™

The liquid nitrogen smart tank and workstation combines the power of TMRW digital innovation with the speed and control of manual storage access

NEW YORK, March 19, 2025 /PRNewswire/ — TMRW Life Sciences (TMRW), the fertility technology company transforming the storage and management of frozen eggs, embryos, and sperm, announced the upcoming launch of its latest offering: TMRW Vault—a state-of-the-art liquid nitrogen smart tank and digital workstation. For the first time, fertility clinics can combine TMRW’s advanced Digital Specimen Management platform with the convenience of a manual storage tank.

Meeting Fertility Clinics Where They Are
Building on the successes of the TMRW cryorobots, the TMRW Vault is the result of years of collaboration with fertility clinics and embryologists. With this addition, TMRW expands its suite of cryostorage options, offering a flexible solution built for every clinic—onsite or offsite, vapor or liquid, manual or automated—all connected to the TMRW digital ecosystem.

“Since 2018, we’ve been developing solutions that modernize and elevate the storage and management of frozen IVF specimens for fertility clinics—and having ingested more than 350,000 specimens, we’ve learned that when it comes to cryostorage, it’s not a one-size-fits-all-clinics approach,” said Louis Villalba, Chief Executive Officer of TMRW Life Sciences. “The TMRW Vault was the missing puzzle piece in our comprehensive cryostorage offering. Now, we have a solution that can adjust to any clinic’s storage needs.”

The Power of Technology, The Speed and Control of Manual Access
The TMRW Vault is a liquid nitrogen tank and digital workstation designed to safely and seamlessly support clinic growth, reduce risk, and increase accuracy.

TMRW Vault Key Benefits Include:

  • Digital Specimen Management: Using RFID technology, patient specimens are tracked in ivfOS®, its proprietary software, and digitally verified at the workstation, helping to reduce the risk of error.
  • Manual Access: Embryologists can store and retrieve specimens directly from the tank for increased speed and efficiency.
  • Scalability: A single Vault tank holds as much as ten traditional dewars, accommodating up to 1,470 patients in one third of the footprint.
  • Advanced Monitoring: TMRW’s Overwatch system performs thousands of daily checks with a team of experts overseeing data.
  • Connected and Flexible: Compatible with the TMRW ecosystem, which makes adopting additional solutions like offsite storage at the TMRW Biorepository fast and seamless.
  • Easy Installation and Mobility: Designed for quick installation—completed in a single day—and streamlined integration into any clinic’s existing workflow.
  • EMR Integration: Connects with clinic EMR systems to minimize manual inputs, eliminate double data entry, and maintain accurate, real-time patient records.

With over 70 partner clinics—representing ~25% of U.S. patient cycle volume—and more than 50,000 patients stored, TMRW has set a new standard for safe management and storage of frozen IVF specimens. Several leading clinics are excited to bring the TMRW Vault into their labs in the coming weeks.

“What truly sets TMRW apart is their dedication to adapting and enhancing their solutions to meet the unique needs of each lab and clinic,” said Bec Holmes, Senior Vice President, Lab Operations at CCRM Fertility. “Their deep understanding of IVF labs and ability to innovate has resulted in a solution that blends technology with the practical demands of everyday operations.”

Fertility clinics can now benefit from the precision and security of TMRW technology with the flexibility to choose the storage solution that best suits their clinic’s needs. The TMRW Vault is a gamechanger for the fertility industry, intended to continue TMRW’s mission to raise the standard of care in the management and storage of frozen eggs, embryos, and sperm.

About TMRW Life Sciences
Founded in 2018, TMRW Life Sciences, Inc., is a fertility technology company digitizing the IVF lab starting with the world’s first automated platform for the safe management and storage of frozen sperm, eggs and embryos. For the first time, frozen specimens can be digitally identified and tracked, safely managed with automated robotics, and remotely monitored around the clock. TMRW’s next-generation technology platforms set a new standard of care, reducing potential points of failure by 94% compared to manual systems. TMRW delivers peace of mind by helping reduce the risk of specimen mix-up, damage, or loss. Named Fast Company’s #1 Most Innovative Biotech company in 2022, TMRW has been adopted by leading clinics across the United States and United Kingdom.

For more information, visit tmrwlifesciences.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/tmrw-life-sciences-announces-launch-of-its-latest-offering-in-frozen-ivf-specimen-management-and-storage-tmrw-vault-302405813.html

SOURCE TMRW Life Sciences

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

2 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

5 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

5 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

5 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

5 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

5 hours ago